Haoxi Health Technology Limited logo

Haoxi Health Technology Limited

HAO

NASDAQCommunication ServicesAdvertising Agencies

Previous close

$3.27

−$0.42 · -11.38%

Aug 21, 4:00 PM ET

HAO company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

65

Undervalued

Momentum

36

Weakening

Sentiment

51

Mixed

Risk resilience

34

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Haoxi Health Technology Limited, operating with its subsidiaries in China, specializes in providing digital marketing services. The company's offerings encompass online short video marketing, which it delivers to advertisers through its network of media partners, alongside custom-designed marketing strategies. These tailored solutions involve the careful planning, creation, distribution, and optimization of online advertisements across various digital platforms, all aimed at helping advertisers attract new customers, drive conversions, and cultivate consumer loyalty. Advertisements are strategically placed on leading online short video and social media platforms, including popular services like Toutiao, Douyin, WeChat, and Sina Weibo. Haoxi primarily serves an advertiser base within the healthcare industry. The company was founded in 2018 and is headquartered in Beijing, China.

Industry
Advertising Agencies
Sector
Communication Services
Headquarters
CN
CEO
Zhen Fan
Listed since
Jan 26, 2024
Employees
26

Market position

Day range

Current $3.27

52-week range

Current $3.27

Open
$3.60
Previous close
$3.69
Volume
75.99K
0.28× average
Average volume
270.73K
Average daily volume
Market cap
1.15M USD
Beta
-1.13
Market reference 1
50-day average
$10.4902
-68.83% below average
200-day average
$1,835.57
-99.82% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
381.78M USD
P/E (TTM)
-1.49×
P/B (TTM)
0.05×
P/S (TTM)
0.03×
EV / EBITDA
83.63×
Earnings yield
1.00%
Free cash flow yield
-0.86%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
4.79%
Operating margin
-17.69%
Net margin
-6.50%
Return on equity
22.31%
Return on assets
17.95%
Return on invested capital
-9.64%

Financial health

Debt / equity
0.1×
Current ratio
5.05×
Altman Z-score
4.99
Piotroski F-score
3 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends14%6%-1%-8%Gross margin, FY2021: 4.71%Gross margin, FY2022: 4.02%Gross margin, FY2023: 7.30%Gross margin, FY2024: 5.67%Gross margin, FY2025: 2.83%Operating margin, FY2021: 2.57%Operating margin, FY2022: 1.66%Operating margin, FY2023: 4.24%Operating margin, FY2024: 3.54%Operating margin, FY2025: -6.10%Net margin, FY2021: 2.37%Net margin, FY2022: 1.51%Net margin, FY2023: 3.44%Net margin, FY2024: 2.66%Net margin, FY2025: 11.82%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 4.71%. Gross margin FY2022 4.02%. Gross margin FY2023 7.30%. Gross margin FY2024 5.67%. Gross margin FY2025 2.83%. Operating margin FY2021 2.57%. Operating margin FY2022 1.66%. Operating margin FY2023 4.24%. Operating margin FY2024 3.54%. Operating margin FY2025 -6.10%. Net margin FY2021 2.37%. Net margin FY2022 1.51%. Net margin FY2023 3.44%. Net margin FY2024 2.66%. Net margin FY2025 11.82%.

Income trends

Revenue

32.8M USD-32.39%

Operating income

−2M USD−3.72M USD

Net income

3.88M USD+200.13%
Income trends across reported periods53.57M USD33.36M USD13.16M USD−7.05M USDRevenue, FY2021: 12.85M USDRevenue, FY2022: 16.16M USDRevenue, FY2023: 28.23M USDRevenue, FY2024: 48.52M USDRevenue, FY2025: 32.8M USDOperating income, FY2021: 330.55K USDOperating income, FY2022: 268.77K USDOperating income, FY2023: 1.2M USDOperating income, FY2024: 1.72M USDOperating income, FY2025: −2M USDNet income, FY2021: 304.07K USDNet income, FY2022: 244.59K USDNet income, FY2023: 969.75K USDNet income, FY2024: 1.29M USDNet income, FY2025: 3.88M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 12.85M USD. Revenue FY2022 16.16M USD. Revenue FY2023 28.23M USD. Revenue FY2024 48.52M USD. Revenue FY2025 32.8M USD. Operating income FY2021 330.55K USD. Operating income FY2022 268.77K USD. Operating income FY2023 1.2M USD. Operating income FY2024 1.72M USD. Operating income FY2025 −2M USD. Net income FY2021 304.07K USD. Net income FY2022 244.59K USD. Net income FY2023 969.75K USD. Net income FY2024 1.29M USD. Net income FY2025 3.88M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue32.8M USD48.52M USD28.23M USD16.16M USD12.85M USD
Cost of goods sold31.88M USD45.77M USD26.17M USD15.51M USD12.24M USD
Gross profit927.75K USD2.75M USD2.06M USD648.72K USD605.58K USD
Research and development79.54K USD79.99K USD58.16K USD102.52K USD62.65K USD
Selling, general, and administrative2.85M USD953.14K USD808.09K USD277.43K USD212.38K USD
Operating expenses2.93M USD1.03M USD866.26K USD379.95K USD275.02K USD
Interest income363.31K USD76.1K USD
Interest expense45.96K USD41.19K USD20.9K USD9.96K USD5.27K USD
Depreciation and amortization371.76K USD10.57K USD8.39K USD2.21K USD411 USD
Operating income−2M USD1.72M USD1.2M USD268.77K USD330.55K USD
Net income3.88M USD1.29M USD969.75K USD244.59K USD304.07K USD

Company facts updated Aug 24, 2026.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

$0.18

2020 complete year-98.8% since 2016

Corporate action history

Dividend

Ex-dividend Feb 12, 2020

$0.18

Semi-Annual

Payment Feb 26, 2020

Dividend

Ex-dividend Dec 23, 2019

$0.0002

Annual

Payment Dec 31, 2019

Dividend

Ex-dividend Dec 24, 2018

$0.0004

Annual

Payment Dec 31, 2018

Dividend

Ex-dividend Dec 26, 2017

$0.0003

Annual

Payment Dec 29, 2017

Dividend

Ex-dividend Dec 23, 2016

$0.0002

Annual

Payment Dec 30, 2016

Dividend

Ex-dividend Dec 24, 2015

$0.0003

Annual

Payment Dec 31, 2015

HAO peers

Continue in GoAI

Research HAO

research.disclaimer